Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

YES: One of the things that bug me the most was the excellent report from the Ph-2 132 patients Parkinson's Dementia and Parkinson (movement) results. With the placebo cohort continuing to decline; the low dose cohort stayed the same as in the beginning of the trial; and the high dose cohort showing that all improved. That PR was June of last year.

Parkinson's Dementia/Parkinson is the #2 most common dementia disease, it is a huge Multi-Billion world wide market. With those results FDA approval is a shoe in since there are zero effective treatment for this debilitating disease.

Another big advantage is unlike Alzheimer, PDD/PD is a much shorter trial than Alzheimer at only 14 weeks. Why an all out effort to start a ph-3 pivotal trial last year for FDA approval is a mystery

Yep that says it all. We're set up for a slam dunk so why isn't this trial completed. Supposedly they needed months to analyze, they got it done. So if a trial had been started immediately that would likely finish up about the same time as alz, and allow us some diversification from a binary result.

People need to pepper Dr. M with questions at the ASM about the tortoise rate of followup trials. We need followup to PDD and PD far more than another rare disease.